A Pilot Placebo Controlled, Double-Blind, Randomized Parallel Group Study to Evaluate the Efficacy of Treatment With CLR3001 in Depression.

Trial Profile

A Pilot Placebo Controlled, Double-Blind, Randomized Parallel Group Study to Evaluate the Efficacy of Treatment With CLR3001 in Depression.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Feb 2015

At a glance

  • Drugs CLR 3001 (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Clera
  • Most Recent Events

    • 03 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 14 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top